chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Feeling abnormal, Gait inability, Vertigo
Clinical narrative: diagnosed with vertigo by HCP; he couldn't walk he felt that he didn't have his balance; issues of not being able to walk; felt that he had a mini stroke; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VERTIGO (diagnosed with vertigo by HCP), BALANCE DISORDER (he couldn't walk he felt that he didn't have his balance), GAIT INABILITY (issues of not being able to walk) and FEELING ABNORMAL (felt that he had a mini stroke) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced BALANCE DISORDER (he couldn't walk he felt that he didn't have his balance), GAIT INABILITY (issues of not being able to walk) and FEELING ABNORMAL (felt that he had a mini stroke). On 16-Mar-2021, the patient experienced VERTIGO (diagnosed with vertigo by HCP). At the time of the report, VERTIGO (diagnosed with vertigo by HCP), BALANCE DISORDER (he couldn't walk he felt that he didn't have his balance), GAIT INABILITY (issues of not being able to walk) and FEELING ABNORMAL (felt that he had a mini stroke) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that his doctor diagnosed him with vertigo on 16mar2021 and the stroke was ruled out. Patient states that he has taken aspirin. Patient did not self-treat after the first dose.   This case was linked to MOD-2021-083659 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dyspepsia, Headache, Tinnitus
Clinical narrative: Indigestion; Ringing in ears; increase in her Blood pressure; headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (Indigestion), TINNITUS (Ringing in ears), BLOOD PRESSURE INCREASED (increase in her Blood pressure) and HEADACHE (headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced DYSPEPSIA (Indigestion), TINNITUS (Ringing in ears), BLOOD PRESSURE INCREASED (increase in her Blood pressure) and HEADACHE (headache). On 16-Apr-2021, DYSPEPSIA (Indigestion) and HEADACHE (headache) had resolved. On 19-Apr-2021, BLOOD PRESSURE INCREASED (increase in her Blood pressure) had resolved. At the time of the report, TINNITUS (Ringing in ears) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Blood pressure measurement: increased (High) blood pressure is increased..         Action taken with  the product mRNA-1273 is not applicable.  Concomitant drug included  blood pressure medications.  Treatment medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Rash pruritic
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (tiny tiny" bumps that are hardly visible on top portion of feet and toes) and RASH PRURITIC ("tiny tiny" bumps are itchy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B214) for COVID-19 vaccination. The patient's past medical history included No adverse event (The patient's medical history was not provided.  On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Apr-2021, the patient experienced RASH PAPULAR (tiny tiny" bumps that are hardly visible on top portion of feet and toes) and RASH PRURITIC ("tiny tiny" bumps are itchy). At the time of the report, RASH PAPULAR (tiny tiny" bumps that are hardly visible on top portion of feet and toes) and RASH PRURITIC ("tiny tiny" bumps are itchy) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. OR Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Fatigue, Headache, Tinnitus
Clinical narrative: tinnitus; headache focused behind her left ear.the pain was her skull behind her left ear; tiredness; headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (tinnitus), EAR PAIN (headache focused behind her left ear.the pain was her skull behind her left ear), FATIGUE (tiredness) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037a21b) for COVID-19 vaccination.     The patient's past medical history included Tinnitus and Colonoscopy. Concomitant products included ANASTROZOLE and VITAMIN D2 from 17-Mar-2021 to an unknown date for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced FATIGUE (tiredness) and HEADACHE (headache). On 06-Apr-2021, the patient experienced TINNITUS (tinnitus) and EAR PAIN (headache focused behind her left ear.the pain was her skull behind her left ear). On 05-Apr-2021, FATIGUE (tiredness) and HEADACHE (headache) had resolved. On 06-Apr-2021, EAR PAIN (headache focused behind her left ear.the pain was her skull behind her left ear) had resolved. At the time of the report, TINNITUS (tinnitus) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not reported.  Patient 2n dose was due 05-may-2021.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Nausea, Pyrexia
Clinical narrative: Weakness 2 weeks after the 1st dose; Fever 2 weeks after the 1st dose; Nausea 2 weeks after the 1st dose; This spontaneous case was reported by a health care professional and describes the occurrence of ASTHENIA (Weakness 2 weeks after the 1st dose), PYREXIA (Fever 2 weeks after the 1st dose) and NAUSEA (Nausea 2 weeks after the 1st dose) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness 2 weeks after the 1st dose), PYREXIA (Fever 2 weeks after the 1st dose) and NAUSEA (Nausea 2 weeks after the 1st dose). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness 2 weeks after the 1st dose), PYREXIA (Fever 2 weeks after the 1st dose) and NAUSEA (Nausea 2 weeks after the 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Concomitant Medication was added.Event outcome was updated.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Flushing, Swelling face
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNEA (Heavy breathing), FLUSHING (hot face), DIZZINESS (Dizzy) and SWELLING FACE (face is still semi swollen) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced DYSPNEA (Heavy breathing), FLUSHING (hot face), DIZZINESS (Dizzy) and SWELLING FACE (face is still semi swollen). At the time of the report, DYSPNOEA (Heavy breathing), FLUSHING (hot face), DIZZINESS (Dizzy) and SWELLING FACE (face is still semi swollen) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rhinorrhoea, Sneezing
Clinical narrative: Runny Nose; Sneezing; Queasy Feeling after Second Shot; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny Nose), SNEEZING (Sneezing) and NAUSEA (Queasy Feeling after Second Shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A)) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced RHINORRHOEA (Runny Nose), SNEEZING (Sneezing) and NAUSEA (Queasy Feeling after Second Shot). On 20-Apr-2021, NAUSEA (Queasy Feeling after Second Shot) had resolved. At the time of the report, RHINORRHOEA (Runny Nose) and SNEEZING (Sneezing) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment medications provided by the reporter.  Action taken with mRNA-1273 in response to the events was not Applicable
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Ear discomfort, Ear pruritus, Erythema, Eye discharge
Clinical narrative: ear itching; Ear burning; mucus in eyes; swollen eyes; difficult breathing; rash on neck, chest, legs, arms; red dots, lines moving across body; hives on face, hair and eyes; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Apr-2021 and was forwarded to Moderna on 21-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on face, hair and eyes), EAR PRURITUS (ear itching), EYE DISCHARGE (mucus in eyes), EYE SWELLING (swollen eyes) and DYSPNOEA (difficult breathing) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (shell fish can cause rash.).    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced URTICARIA (hives on face, hair and eyes), EYE DISCHARGE (mucus in eyes), EYE SWELLING (swollen eyes), DYSPNOEA (difficult breathing), RASH (rash on neck, chest, legs, arms) and ERYTHEMA (red dots, lines moving across body). On an unknown date, the patient experienced EAR PRURITUS (ear itching). At the time of the report, URTICARIA (hives on face, hair and eyes), EAR PRURITUS (ear itching), EYE DISCHARGE (mucus in eyes), EYE SWELLING (swollen eyes), DYSPNOEA (difficult breathing), RASH (rash on neck, chest, legs, arms) and ERYTHEMA (red dots, lines moving across body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Rash, Urticaria
Clinical narrative: ear itching; Ear burning; mucus in eyes; swollen eyes; difficult breathing; rash on neck, chest, legs, arms; red dots, lines moving across body; hives on face, hair and eyes; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Apr-2021 and was forwarded to Moderna on 21-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on face, hair and eyes), EAR PRURITUS (ear itching), EYE DISCHARGE (mucus in eyes), EYE SWELLING (swollen eyes) and DYSPNOEA (difficult breathing) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (shell fish can cause rash.).    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced URTICARIA (hives on face, hair and eyes), EYE DISCHARGE (mucus in eyes), EYE SWELLING (swollen eyes), DYSPNOEA (difficult breathing), RASH (rash on neck, chest, legs, arms) and ERYTHEMA (red dots, lines moving across body). On an unknown date, the patient experienced EAR PRURITUS (ear itching). At the time of the report, URTICARIA (hives on face, hair and eyes), EAR PRURITUS (ear itching), EYE DISCHARGE (mucus in eyes), EYE SWELLING (swollen eyes), DYSPNOEA (difficult breathing), RASH (rash on neck, chest, legs, arms) and ERYTHEMA (red dots, lines moving across body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Hyperhidrosis
Clinical narrative: Sweating; Headaches; Body aches; Nausea; 104°f fever; Chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea) and PYREXIA (104°f fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (104°f fever), CHILLS (Chills) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (104°f fever), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 104 (High) 104 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Stomach medication was used as a concomitant medication. Action taken with the product mRNA-1273 was not Applicable.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Sweating; Headaches; Body aches; Nausea; 104°f fever; Chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea) and PYREXIA (104°f fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (104°f fever), CHILLS (Chills) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (104°f fever), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 104 (High) 104 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Stomach medication was used as a concomitant medication. Action taken with the product mRNA-1273 was not Applicable.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Sinus headache
Clinical narrative: Originates in Sinuses; Tired; Severe Headache & headache comes and go; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe Headache & headache comes and go), SINUS HEADACHE (Originates in Sinuses) and FATIGUE (Tired) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (Severe Headache & headache comes and go). On an unknown date, the patient experienced SINUS HEADACHE (Originates in Sinuses) and FATIGUE (Tired). At the time of the report, HEADACHE (Severe Headache & headache comes and go), SINUS HEADACHE (Originates in Sinuses) and FATIGUE (Tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-083106, US-MODERNATX, INC.-MOD-2021-083535 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083106:Brother case US-MODERNATX, INC.-MOD-2021-083535:Son's case
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My arm felt like it got hit with a sledge hammer; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm felt like it got hit with a sledge hammer) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (My arm felt like it got hit with a sledge hammer). At the time of the report, PAIN IN EXTREMITY (My arm felt like it got hit with a sledge hammer) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medications were reported.   Reporter did not allow further contact
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Neck pain, Vertigo
Clinical narrative: Pain in neck; Pain in skull; mild vertigo; Prolonged Headaches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VERTIGO (mild vertigo), NECK PAIN (Pain in neck), HEADACHE (Prolonged Headaches) and HEADACHE (Pain in skull) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced VERTIGO (mild vertigo) and HEADACHE (Prolonged Headaches). On an unknown date, the patient experienced NECK PAIN (Pain in neck) and HEADACHE (Pain in skull). At the time of the report, VERTIGO (mild vertigo), NECK PAIN (Pain in neck), HEADACHE (Prolonged Headaches) and HEADACHE (Pain in skull) outcome was unknown.            No concomitant medications reported. The patient took Aspirin, also had taken up to 6400 mg taking Ibuprofen over a series of days. Patient stated that he took 800 mg of Ibuprofen every 12 hours, also took pain killers .   This case was linked to MOD-2021-083632 (Patient Link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature abnormal, Chills, Nervousness
Clinical narrative: Chills; Shaky; temperature is 55.6; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), NERVOUSNESS (Shaky) and BODY TEMPERATURE ABNORMAL (temperature is 55.6) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced CHILLS (Chills), NERVOUSNESS (Shaky) and BODY TEMPERATURE ABNORMAL (temperature is 55.6). At the time of the report, CHILLS (Chills), NERVOUSNESS (Shaky) and BODY TEMPERATURE ABNORMAL (temperature is 55.6) outcome was unknown. Unknown          This case was linked to MOD-2021-054712 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Breast pain, Fibromyalgia, Injection site pain, Neck pain
Clinical narrative: Fibromyalgia pain escalated after second dose; pain involving trigger points in lower neck; edge of upper breast; worse pain in hipbones,upper and outer shoulders; Trigger points that had not been affected before are now affected.; Sore Injection Site (After the first Shot); This spontaneous case was reported by a health care professional and describes the occurrence of FIBROMYALGIA (Fibromyalgia pain escalated after second dose), NECK PAIN (pain involving trigger points in lower neck), BREAST PAIN (edge of upper breast), BONE PAIN (worse pain in hipbones,upper and outer shoulders) and PAIN (Trigger points that had not been affected before are now affected.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer. Concurrent medical conditions included Fibromyalgia (fibromyalgia for 40 years.). Concomitant products included CEFIXIME (FLEXERIL [CEFIXIME]) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Jan-2021, the patient experienced FIBROMYALGIA (Fibromyalgia pain escalated after second dose), NECK PAIN (pain involving trigger points in lower neck), BREAST PAIN (edge of upper breast), BONE PAIN (worse pain in hipbones,upper and outer shoulders), PAIN (Trigger points that had not been affected before are now affected.) and INJECTION SITE PAIN (Sore Injection Site (After the first Shot)). At the time of the report, FIBROMYALGIA (Fibromyalgia pain escalated after second dose), NECK PAIN (pain involving trigger points in lower neck), BREAST PAIN (edge of upper breast), BONE PAIN (worse pain in hipbones,upper and outer shoulders), PAIN (Trigger points that had not been affected before are now affected.) and INJECTION SITE PAIN (Sore Injection Site (After the first Shot)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant:  Suspect #1: Medication Flexeril 10 mg. Suspect #2: Medication NSAIDS as needed, not often. Treatment Flexeril, NSAIDS, myofacial release chiropractic adjustments.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: The follow up information document which received on 25-MAY-2021. Second dosage information is added . Events were added.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Fibromyalgia pain escalated after second dose; pain involving trigger points in lower neck; edge of upper breast; worse pain in hipbones,upper and outer shoulders; Trigger points that had not been affected before are now affected.; Sore Injection Site (After the first Shot); This spontaneous case was reported by a health care professional and describes the occurrence of FIBROMYALGIA (Fibromyalgia pain escalated after second dose), NECK PAIN (pain involving trigger points in lower neck), BREAST PAIN (edge of upper breast), BONE PAIN (worse pain in hipbones,upper and outer shoulders) and PAIN (Trigger points that had not been affected before are now affected.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer. Concurrent medical conditions included Fibromyalgia (fibromyalgia for 40 years.). Concomitant products included CEFIXIME (FLEXERIL [CEFIXIME]) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Jan-2021, the patient experienced FIBROMYALGIA (Fibromyalgia pain escalated after second dose), NECK PAIN (pain involving trigger points in lower neck), BREAST PAIN (edge of upper breast), BONE PAIN (worse pain in hipbones,upper and outer shoulders), PAIN (Trigger points that had not been affected before are now affected.) and INJECTION SITE PAIN (Sore Injection Site (After the first Shot)). At the time of the report, FIBROMYALGIA (Fibromyalgia pain escalated after second dose), NECK PAIN (pain involving trigger points in lower neck), BREAST PAIN (edge of upper breast), BONE PAIN (worse pain in hipbones,upper and outer shoulders), PAIN (Trigger points that had not been affected before are now affected.) and INJECTION SITE PAIN (Sore Injection Site (After the first Shot)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant:  Suspect #1: Medication Flexeril 10 mg. Suspect #2: Medication NSAIDS as needed, not often. Treatment Flexeril, NSAIDS, myofacial release chiropractic adjustments.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: The follow up information document which received on 25-MAY-2021. Second dosage information is added . Events were added.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: m her fingers in her right had began to have a tingling sensation; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (m her fingers in her right had began to have a tingling sensation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced PARAESTHESIA (m her fingers in her right had began to have a tingling sensation). At the time of the report, PARAESTHESIA (m her fingers in her right had began to have a tingling sensation) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Updated the event outcome
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose delayed beyond 42 days; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose delayed beyond 42 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose delayed beyond 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose delayed beyond 42 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.  Treatment medications was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received and updated non significant information such as contact information confirmed and case information updated.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Menstruation irregular, Pyrexia, Vomiting
Clinical narrative: menstrual cycle started early and still has it; Fever; Chills; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (menstrual cycle started early and still has it), PYREXIA (Fever), CHILLS (Chills) and VOMITING (Vomiting) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and VOMITING (Vomiting). On 17-Apr-2021, the patient experienced MENSTRUATION IRREGULAR (menstrual cycle started early and still has it). On 11-Apr-2021, PYREXIA (Fever), CHILLS (Chills) and VOMITING (Vomiting) had resolved. At the time of the report, MENSTRUATION IRREGULAR (menstrual cycle started early and still has it) outcome was unknown.            No treatment information was provided Concomitant medication included unspecified birth control pill. .
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm (After First Vaccine); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm (After First Vaccine)) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm (After First Vaccine)). On 25-Mar-2021, PAIN IN EXTREMITY (Sore Arm (After First Vaccine)) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications provided. No treatment information provided.   This case was linked to MOD-2021-083716 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Cough, Illness, Nasopharyngitis, Oropharyngeal pain
Clinical narrative: Feel to be a simple common cold; Sore throat; Head cold; Cough; On a scale from 1 to 10 their sickness level is about a 5; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Feel to be a simple common cold), OROPHARYNGEAL PAIN (Sore throat), NASOPHARYNGITIS (Head cold), COUGH (Cough) and ILLNESS (On a scale from 1 to 10 their sickness level is about a 5) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concomitant products included DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NASOPHARYNGITIS (Feel to be a simple common cold), OROPHARYNGEAL PAIN (Sore throat), NASOPHARYNGITIS (Head cold), COUGH (Cough) and ILLNESS (On a scale from 1 to 10 their sickness level is about a 5). At the time of the report, NASOPHARYNGITIS (Feel to be a simple common cold), OROPHARYNGEAL PAIN (Sore throat), NASOPHARYNGITIS (Head cold), COUGH (Cough) and ILLNESS (On a scale from 1 to 10 their sickness level is about a 5) outcome was unknown.             Treatment medications were unknown.   Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: AE details and outcome added
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling; pins and needles; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling) and PARAESTHESIA (pins and needles) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced PARAESTHESIA (tingling) and PARAESTHESIA (pins and needles). At the time of the report, PARAESTHESIA (tingling) and PARAESTHESIA (pins and needles) had not resolved. Not Provided          Concomitant medication include birth control  Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling of body temperature change, Headache, Nausea, Pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore right arm), feeling abnormal (not feeling good), feeling of body temperature change (feeling warm and freezing), pain (body hurting) and headache in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 043B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 21, 2021, patient experienced pain in extremity (sore right arm), feeling abnormal (not feeling good), feeling of body temperature change (feeling warm and freezing), pain (body hurting), headache and nausea. The patient treated with Motrin (ibuprofen), at an unspecified dose and frequency; and Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, pain in extremity (sore right arm), feeling abnormal (not feeling good), feeling of body temperature change (feeling warm and freezing), pain (body hurting), headache and nausea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore right arm), feeling abnormal (not feeling good), feeling of body temperature change (feeling warm and freezing), pain (body hurting) and headache in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 043B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 21, 2021, patient experienced pain in extremity (sore right arm), feeling abnormal (not feeling good), feeling of body temperature change (feeling warm and freezing), pain (body hurting), headache and nausea. The patient treated with Motrin (ibuprofen), at an unspecified dose and frequency; and Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, pain in extremity (sore right arm), feeling abnormal (not feeling good), feeling of body temperature change (feeling warm and freezing), pain (body hurting), headache and nausea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Feeling of relaxation, Pain, Pain in extremity
Clinical narrative: Her arm still hurts; she just started to recover from it.; Unlike the first dose where her pain was concentrated in her hip and tooth, the second dose caused pain in every part of her body including fingers, arms, head, and neck.; Chills; Fever; Swollen arm; Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home; "It was horrible!"; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING ABNORMAL (Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home), FEELING ABNORMAL ("It was horrible!"), PAIN IN EXTREMITY (Her arm still hurts) and FEELING OF RELAXATION (she just started to recover from it.) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING ABNORMAL (Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home), FEELING ABNORMAL ("It was horrible!"), PAIN (Unlike the first dose where her pain was concentrated in her hip and tooth, the second dose caused pain in every part of her body including fingers, arms, head, and neck.), CHILLS (Chills) and PYREXIA (Fever). On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (Her arm still hurts) and FEELING OF RELAXATION (she just started to recover from it.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING ABNORMAL (Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home), FEELING ABNORMAL ("It was horrible!"), PAIN IN EXTREMITY (Her arm still hurts), FEELING OF RELAXATION (she just started to recover from it.), PAIN (Unlike the first dose where her pain was concentrated in her hip and tooth, the second dose caused pain in every part of her body including fingers, arms, head, and neck.), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. Not Provided          No relevant concomitant medication was reported.   This case was linked to MOD-2021-083557 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Her arm still hurts; she just started to recover from it.; Unlike the first dose where her pain was concentrated in her hip and tooth, the second dose caused pain in every part of her body including fingers, arms, head, and neck.; Chills; Fever; Swollen arm; Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home; "It was horrible!"; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING ABNORMAL (Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home), FEELING ABNORMAL ("It was horrible!"), PAIN IN EXTREMITY (Her arm still hurts) and FEELING OF RELAXATION (she just started to recover from it.) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING ABNORMAL (Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home), FEELING ABNORMAL ("It was horrible!"), PAIN (Unlike the first dose where her pain was concentrated in her hip and tooth, the second dose caused pain in every part of her body including fingers, arms, head, and neck.), CHILLS (Chills) and PYREXIA (Fever). On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (Her arm still hurts) and FEELING OF RELAXATION (she just started to recover from it.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING ABNORMAL (Both her doses caused her side effects to be so terrible she felt as if she may have to be admitted into the nursing home), FEELING ABNORMAL ("It was horrible!"), PAIN IN EXTREMITY (Her arm still hurts), FEELING OF RELAXATION (she just started to recover from it.), PAIN (Unlike the first dose where her pain was concentrated in her hip and tooth, the second dose caused pain in every part of her body including fingers, arms, head, and neck.), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. Not Provided          No relevant concomitant medication was reported.   This case was linked to MOD-2021-083557 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Headache, Hypersomnia, Malaise
Clinical narrative: Pain in her back is worse; extends from lower back to sciatic nerve; Pain extends into her lower legs; Headache flared up; Felt dragged out/tired, no energy, sleeping later than used to/general dragged out malaise/Still feeling very tired; General dragged out malaise; Sleeping later than used to; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (Pain in her back is worse; extends from lower back to sciatic nerve), MALAISE (General dragged out malaise), HYPERSOMNIA (Sleeping later than used to), PAIN IN EXTREMITY (Pain extends into her lower legs) and HEADACHE (Headache flared up) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back surgery in 2015.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced MALAISE (General dragged out malaise), HYPERSOMNIA (Sleeping later than used to) and FATIGUE (Felt dragged out/tired, no energy, sleeping later than used to/general dragged out malaise/Still feeling very tired). On an unknown date, the patient experienced BACK PAIN (Pain in her back is worse; extends from lower back to sciatic nerve), PAIN IN EXTREMITY (Pain extends into her lower legs) and HEADACHE (Headache flared up). At the time of the report, BACK PAIN (Pain in her back is worse; extends from lower back to sciatic nerve), PAIN IN EXTREMITY (Pain extends into her lower legs), HEADACHE (Headache flared up) and FATIGUE (Felt dragged out/tired, no energy, sleeping later than used to/general dragged out malaise/Still feeling very tired) had not resolved and MALAISE (General dragged out malaise) and HYPERSOMNIA (Sleeping later than used to) outcome was unknown.            The patient reported requiring extra pain medication (not specified) due to aggravated back pain.     This case was linked to US-MODERNATX, INC.-MOD-2021-083531, MOD21-079646, MOD21-091983, US-MODERNATX, INC.-MOD-2021-149581 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: New event of headache added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083531: MOD21-079646:cross linked id MOD21-091983:cross linked id US-MODERNATX, INC.-MOD-2021-149581: